Ameriprise’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
99,044
-14,335
| -13% | -$201K | ﹤0.01% | 3113 |
|
|
2025
Q1 | $1.77M | Sell |
113,379
-26,550
| -19% | -$415K | ﹤0.01% | 2940 |
|
|
2024
Q4 | $1.95M | Buy |
139,929
+50,662
| +57% | +$706K | ﹤0.01% | 2924 |
|
|
2024
Q3 | $830K | Buy |
89,267
+11,861
| +15% | +$110K | ﹤0.01% | 3280 |
|
|
2024
Q2 | $720K | Sell |
77,406
-16,534
| -18% | -$154K | ﹤0.01% | 3302 |
|
|
2024
Q1 | $931K | Sell |
93,940
-985,640
| -91% | -$9.77M | ﹤0.01% | 3192 |
|
|
2023
Q4 | $3.49M | Buy |
+1,079,580
| New | +$3.49M | ﹤0.01% | 2589 |
|
|
2023
Q3 | – | Sell |
-337,052
| Closed | -$3.21M | – | 3888 |
|
|
2023
Q2 | $3.21M | Sell |
337,052
-517,682
| -61% | -$4.93M | ﹤0.01% | 2632 |
|
|
2023
Q1 | $9.4M | Buy |
854,734
+41,112
| +5% | +$452K | ﹤0.01% | 1821 |
|
|
2022
Q4 | $12M | Buy |
813,622
+158,944
| +24% | +$2.35M | ﹤0.01% | 1587 |
|
|
2022
Q3 | $12.5M | Buy |
654,678
+110,490
| +20% | +$2.11M | ﹤0.01% | 1489 |
|
|
2022
Q2 | $11.6M | Buy |
544,188
+113,926
| +26% | +$2.43M | ﹤0.01% | 1619 |
|
|
2022
Q1 | $8.29M | Buy |
430,262
+213,859
| +99% | +$4.12M | ﹤0.01% | 2058 |
|
|
2021
Q4 | $4.49M | Sell |
216,403
-145,632
| -40% | -$3.02M | ﹤0.01% | 2546 |
|
|
2021
Q3 | $8.66M | Buy |
362,035
+7,155
| +2% | +$171K | ﹤0.01% | 1970 |
|
|
2021
Q2 | $9.69M | Buy |
354,880
+37,677
| +12% | +$1.03M | ﹤0.01% | 1962 |
|
|
2021
Q1 | $9.18M | Buy |
317,203
+202,086
| +176% | +$5.85M | ﹤0.01% | 1952 |
|
|
2020
Q4 | $3.24M | Sell |
115,117
-169,329
| -60% | -$4.76M | ﹤0.01% | 2545 |
|
|
2020
Q3 | $8.33M | Buy |
284,446
+6,427
| +2% | +$188K | ﹤0.01% | 1681 |
|
|
2020
Q2 | $8.41M | Buy |
278,019
+23,580
| +9% | +$713K | ﹤0.01% | 1658 |
|
|
2020
Q1 | $7.58M | Buy |
+254,439
| New | +$7.58M | ﹤0.01% | 1594 |
|